BioCardia Inc (BCDA)
2.02
-0.33
(-14.04%)
USD |
NASDAQ |
Nov 14, 16:00
2.02
0.00 (0.00%)
After-Hours: 20:00
BioCardia Free Cash Flow (Quarterly): -1.315M for June 30, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -1.315M |
| March 31, 2024 | -1.53M |
| December 31, 2023 | -1.851M |
| September 30, 2023 | -2.412M |
| June 30, 2023 | -3.153M |
| March 31, 2023 | -2.57M |
| December 31, 2022 | -2.999M |
| September 30, 2022 | -2.02M |
| June 30, 2022 | -2.67M |
| March 31, 2022 | -2.942M |
| December 31, 2021 | -3.016M |
| September 30, 2021 | -2.663M |
| June 30, 2021 | -2.893M |
| March 31, 2021 | -1.91M |
| December 31, 2020 | -3.417M |
| September 30, 2020 | -3.627M |
| June 30, 2020 | -2.347M |
| March 31, 2020 | -2.998M |
| December 31, 2019 | -3.258M |
| September 30, 2019 | -1.492M |
| June 30, 2019 | -2.321M |
| March 31, 2019 | -2.52M |
| December 31, 2018 | -3.261M |
| September 30, 2018 | -2.014M |
| June 30, 2018 | -2.819M |
| Date | Value |
|---|---|
| March 31, 2018 | -3.041M |
| December 31, 2017 | -2.554M |
| September 30, 2017 | -1.784M |
| June 30, 2017 | -2.127M |
| March 31, 2017 | -2.342M |
| December 31, 2016 | -11.12M |
| September 30, 2016 | 5.565M |
| June 30, 2016 | -0.053M |
| March 31, 2016 | 0.085M |
| December 31, 2015 | 0.114M |
| September 30, 2015 | 0.038M |
| June 30, 2015 | 0.09M |
| March 31, 2015 | 0.089M |
| December 31, 2014 | 0.053M |
| September 30, 2014 | 0.055M |
| June 30, 2014 | 0.079M |
| March 31, 2014 | 0.027M |
| December 31, 2013 | 0.032M |
| September 30, 2013 | -0.006M |
| June 30, 2013 | 0.015M |
| March 31, 2013 | -0.014M |
| December 31, 2012 | 0.445M |
| September 30, 2012 | -0.061M |
| June 30, 2012 | -0.668M |
| March 31, 2012 | -0.026M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-3.627M
Minimum
Sep 2020
-1.315M
Maximum
Jun 2024
-2.610M
Average
-2.67M
Median
Jun 2022
Free Cash Flow (Quarterly) Benchmarks
| Alnylam Pharmaceuticals Inc | 39.52M |
| The Cooper Companies Inc | 118.50M |
| Theriva Biologics Inc | -3.453M |
| Zevra Therapeutics Inc | -19.11M |
| Instil Bio Inc | -10.61M |